RHAPSODY-2: ZZ-3K3A-301: A Multicenter, Randomized, Placebo-Controlled, Double-Blinded, Phase 3 Study To Evaluate The Efficacy And Safety Of 3K3A-APC, A Recombinant Variant Of Human Activated Protein C, In Combination With Tissue Plasminogen Activator, Me
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Neuroscience
Pharmacology, Toxicology and Pharmaceutical Science